Researchers create advanced brain organoid to model strokes, screen drugs

Wake Forest researchers create advanced brain organoid to model strokes, screen drugs
Illustrated damage to the blood brain barrier under ischemic conditions. Credit: WFIRM

Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have developed a 3-D brain organoid that could have potential applications in drug discovery and disease modeling. This is the first engineered tissue equivalent to closely resemble normal human brain anatomy, containing all six major cell types found in normal organs including, neurons and immune cells.

In a study published this month in Scientific Reports, the researchers report that their advanced 3-D organoids promote the formation of a fully cell-based, natural and functional barrier—the —that mimics normal human anatomy.

The blood barrier is a semipermeable membrane that separates the circulating blood from the brain, protecting it from foreign substances that could cause injury. This development is important because the model can help to further understanding of disease mechanisms at the blood brain barrier, the passage of drugs through the barrier, and the effects of drugs once they cross the barrier.

"The shortage of effective therapies and low success rate of investigational drugs are due in part because we do not have a human-like tissue models for testing," said senior author Anthony Atala, M.D., director of WFIRM. "The development of tissue engineered 3-D brain tissue equivalents such as these can help advance the science toward better treatments and improve patients' lives."

The development of the model opens the door to speedier discovery and screening, both for neurological conditions and for diseases like HIV where pathogens hide in the brain and avoid current treatments that cannot cross the blood brain barrier. It may also allow for disease modeling of neurological conditions such as Alzheimer's disease, multiple sclerosis and Parkinson's so that researchers can better understand their pathways and progression.

Thus far the researchers have used the brain organoids to mimic strokes in order to measure impairment of the blood brain barrier and have successfully tested the model's permeability with large and small molecules.

"Using an engineered tissue model provides a platform that can be used to understand the fundamental principles at play with the brain and its function, as well as the effects of chemical substances that cross it," said Goodwell Nzou, a Ph.D. candidate at WFIRM who co-authored the paper.


Explore further

New model may help science overcome the brain's fortress-like barrier

More information: Goodwell Nzou et al, Human Cortex Spheroid with a Functional Blood Brain Barrier for High-Throughput Neurotoxicity Screening and Disease Modeling, Scientific Reports (2018). DOI: 10.1038/s41598-018-25603-5
Provided by Wake Forest University Baptist Medical Center
Citation: Researchers create advanced brain organoid to model strokes, screen drugs (2018, May 29) retrieved 17 February 2019 from https://medicalxpress.com/news/2018-05-advanced-brain-organoid-screen-drugs.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
36 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more